期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

射血分数保留的心力衰竭现状与挑战 被引量：15

Heart failure with preserved ejection fraction： current status and challenges
下载PDF
导出
摘要 心力衰竭（简称心衰）是由于心脏结构或功能异常导致心室充盈或射血能力受损的临床综合征,其主要临床表现为呼吸困难、乏力和液体潴留.心衰为各种心脏疾病的严重和终末阶段,也是心脏病患者的主要死亡因素之一[1,2].依据左心室射血分数（LVEF）,心衰可分为LVEF降低的心衰（HFrEF）和LVEF保留的心衰（HFpEF）.近年来HFpEF患病率相对于HFrEF明显增加,本文就HFpEF的现状及面临的挑战进行阐述.
作者 师树田 聂绍平
机构地区 首都医科大学附属北京安贞医院急诊中心
出处 《中国心血管病研究》 CAS 2015年第5期394-397,共4页 Chinese Journal of Cardiovascular Research
基金 首都临床特色应用研究重点项目（项目编号：Z141107002514014） 北京市自然科学重点项目（项目编号：7141003）
关键词 心力衰竭 保留射血分数 舒张功能障碍 Heart failure： Preserved ejection fraction： Diastolic dysfunction
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献24

  • 1郑刚.急性心力衰竭现状和预后评估的临床证据[J].中国心血管病研究,2008,6(8):561-563. 被引量：17
  • 2郑刚.急性心力衰竭现状和预后评估的临床证据(续)[J].中国心血管病研究,2008,6(9):641-642. 被引量：7
  • 3Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction:pathophysiology, diagnosis, and treatment. Eur Heart J, 2011,32:670-679.
  • 4Brouwers FP, de Boer RA, van der Harst P, et al. Incidence and epidemiology of new onset heart failure with preserved vs reduced ejection fraction in a community-based cohort:ll-year follow-up of PREVEND. Eur Heart J, 2013,34:1424-1431.
  • 5Gladden JD, Linke WA, Redfield MM. Heart failure with preserved ejection fraction. Pflugers Arch, 2014,466:1037-1053.
  • 6Borlaug BA. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction. Circ J,2014,78:20-32.
  • 7Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA Guideline for the Management of Heart Failure:Executive Summary:a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation, 2013,128:1810-1852.
  • 8From AM, Lain CS, Pitta SR, et al. Bedside assessment of cardiac hemodynamics:the impact of noninvasive testing and examiner experience. Am J Med, 2011,124:1051-1057.
  • 9Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure:a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J, 2007,28:2539-2550.
  • 10Andersen MJ, Borlaug BA. Heart failure with preserved ejection fraction:current understandings and challenges. Curr Cardiol Rep, 2014,16:501.

二级参考文献21

  • 1[1]Rosamond W,Flegal K,Friday G,et al.Heart Disease and Stroke Slat-istics-2007 Update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.Circulation,2007,115:e69-e171.
  • 2[3]Cleland JG,Swedberg K,Follath F,et al.Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology.Eur Heart J.The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe.Part 1:patient characteristics and diagnosis.Eur Heart J,2003,24:442-463.
  • 3[4]Siirila-waris K,Lassos J,Melin J,et al.Characteristics,outcomes,and predictors of 1-year mortality in patients hospitalized for acute heart failure.Eur Heart J,2006,27:3011-3017.
  • 4[5]Nieminen MS,Brutsaert D,Diekstein K,et al,EuroHeart Survey Invest-igators:Heart Failure Association,European Society of Cardiology.EuroHeart Failure Survey Ⅱ(EHFS Ⅱ):a survey on hospitalized acute heart failure patients:description of population.Eur Heart J,2006,27:2725-2736.
  • 5[6]Gheorghiade M,Abraham WT,Albert NM,et al.OPTIMIZE-HF Investigators and Coordinators.Systolic blood pressure at admission,clinical characteristics,and outcomes in patients hospitalized with acute heart failure.JAMA,2006,296:2217-2226.
  • 6[7]Peacock WF 4th,De Marco T,Fonarow GC,et al.ADHERE Investigators.Cardiac troponin and outcome in acute heart failure.N Engl J Mad,2008,358:2117-2126.
  • 7[8]Mogelvang R,Goetze JP,Schnohr P,et al.Copenhagen City Heart Study.Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide.J Am Coll Cardiol,2007,50:1694-1701.
  • 8[9]Maisel A.Circulating natriuretic peptide levels in acute heart failure.Rev Cardiovasc Med,2007,8(Suppl 5):S13-21.
  • 9[10]Cleland JG,Coletta AP,Abdellah AT,et al.Clinical trials update from the American Heart Association 2006:OAT,SALT 1 and 2,MAGIC,ABCD,PABA-CHF,IMPROVE-CHF.and percutaneous mitral armuloplesty.Eur J Heart Fail,2007,9:92-97.
  • 10[11]Brenden CK,Hollander JE,Guss D,et al,Gray zone BNP levels heart failure patients in the emergency department:results from the Rapid Emergency Department Heart Failure Outpatient Trial(REDHOT)multicenter study.Am Heart J,2006,151:1013-1018.

共引文献16

同被引文献108

引证文献15

二级引证文献111

中国心血管病研究
2015年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部